Excursion systolique dans le plan de l'anneau mitral : une méthode simple pour identifier les cicatrices myocardiques détectées par les séquences de rehaussements tardifs en IRM dans la cardiomyopathie hypertrophique
La distribution septale de l'hypertrophie et des plages de rehaussement tardif a été identifiée par une considérable diminution des mesures du MAPSE septal par rapport au MAPSE latéral. Une diminution du MAPSE pourrait donc représenter une mesure simple pour identifier les cicatrices myocardiques dans la CMH et semble avoir un rôle pronostique défavorable. © 2015 Elsevier Masson SAS. Tous droits réservés.
Background
Hypertrophic cardiomyopathy (HCM) is a complex form of genetic heart disease. Macroscopically, HCM is characterized by marked, frequently asymmetrical left ventricular hypertrophy in the absence of other causes, such as hypertension or valve disease. Histopathologically, it is associated with cardiomyocyte and cardiac hypertrophy, myocyte disarray, interstitial and replacement fibrosis, and dysplastic intramyocardial arterioles, which are all thought to interfere with myocardial force generation and relaxation [1, 2] . Late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging is able to visualize myocardial fibrosis [3, 4] associated with left ventricular systolic and diastolic dysfunction.
Mitral annular plane systolic excursion (MAPSE) can easily be assessed echocardiographically and correlates with systolic longitudinal ventricular systolic function, parameters of diastolic function (such as early diastolic filling/early diastolic mitral annular velocity [E/E ] and mitral flow propagation velocity) as well as left ventricular twist and torsion [5] . MAPSE can be determined either on the lateral [6, 7] or septal annular site [8] or is given as the average between the measurements at the septal and lateral annular site [5] .
In HCM, regions most affected by the hypertrophic process are the septum and the base [9] . Furthermore, myocardial fibrosis is known to be most pronounced at the junction of the septum and the left ventricular and right ventricular free wall where myofibrillar disarray is maximal [10] . Therefore, we assumed that the septal MAPSE would be most affected.
To date, there are no data available on MAPSE measurements using state of the art CMR, and cut-off values are derived from echocardiography. Thus, the primary aim of our study was to determine the values for septal, lateral and average MAPSE in healthy controls using CMR. Secondly, we determined these values in patients with HCM and compared them among patient subgroups and to healthy controls. Thirdly, we investigated whether MAPSE correlated with the extent of fibrosis.
Methods

Study population
Consecutive patients with HCM referred for CMR were enrolled between January 2004 and December 2012 at our hospital. The population included 45 patients as reported earlier [11] . All patients with HCM were diagnosed based on conventional criteria: left ventricular hypertrophy ≥ 15 mm on two-dimensional echocardiography in the absence of another disease that could account for the hypertrophy [12] . Hypertrophic non-obstructive cardiomyopathy (HNCM) was defined as a pressure gradient ≤ 30 mmHg at rest and after provocation. Patients with a pressure gradient > 30 mmHg at rest or after provocation were classified as having hypertrophic obstructive cardiomyopathy (HOCM).
Age-and sex-matched healthy subjects served as controls and satisfied the following criteria: normal physical examination, normal blood pressure (< 130/85 mmHg), normal electrocardiographic findings, no history of chest pain or dyspnoea, no diabetes, no hyperlipidaemia and normal twodimensional echocardiography and Doppler examination. None of the control subjects was on medication. Exclusion criteria for healthy controls were: the presence of signs or symptoms of cardiac diseases, hypertension or diabetes; smoking; or participation in competitive sports.
The study design complied with the declaration of Helsinki and was approved by local ethical committee, Medical Ethic Commission II, Faculty of Medicine Mannheim, University of Heidelberg, Germany. Written informed consent was obtained from all participants and data were analysed anonymously.
CMR image acquisition
All studies were performed using a 1.5-Tesla whole body imaging system (Magnetom Avanto and Sonata, Siemens Medical Systems, Healthcare Sector, Erlangen, Germany) using a four-element (Sonata) or six-element (Avanto) phased-array body coil.
Cine images were acquired using a retrospective electrocardiographic-gated, balanced segmented steady state free precession (trueFISP) sequence in three longaxis views (2-, 3-, and 4-chamber views) and in multiple short-axis views, covering the entire left ventricle from base to apex. LGE images were obtained 10-15 minutes after intravenous administration of 0.2 mmol/kg gadoteric acid (Dotarem, Guerbet, Roissy CdG Cedex, France), using an inversion recovery turbo Fast Low Angle Shot sequence at the same position as the long-and short-axis cine acquisitions in end-diastole [13] . The inversion time was adjusted by patient to optimally null the signal from normal myocardium, typically 250-300 ms.
CMR image analysis
Left ventricular mass and volumes [14] as well as right ventricular [15] and left atrial volumes [16] were determined using CMR as previously described. The left ventricular remodelling index (LVRI) was determined as the ratio of left ventricular end-diastolic mass (LV-EDM) to left ventricular end-diastolic volume (LV-EDV) [17] . MAPSE measurements Figure 1 . Mitral annular plane systolic excursion (MAPSE) using cardiovascular magnetic resonance (CMR) was measured on the fourchamber cine image at (A) end-diastole and (B) end-systole. Comparable to echocardiography, two separate reference lines were drawn in diastole and systole from the basal septal (septal MAPSE) and lateral side of the atrioventricular plane (lateral MAPSE) to a reference point outside the left ventricular (LV) apex. The point outside the left ventricular apex was chosen in extension to the left ventricular apex and had to stay unchanged at end-diastole and end-systole. In order to ensure that the reference point outside the left ventricular apex stayed unchanged during end-systole, we left the curser at the point of the chosen reference point while scrolling from end-diastole to endsystole. Septal and lateral MAPSE as indicated by the red lines in B were defined as the difference between septal or lateral left ventricular end-diastolic length (LVEDL septal or LVEDL lateral ) (A) and septal or lateral left ventricular end-systolic length (LVESL septal or LVESL lateral ) (B), respectively.
were assessed on four-chamber view cine images. The distance between the basal septal mitral annulus (septal MAPSE), the basal lateral mitral annulus (lateral MAPSE) and a reference point outside the left ventricular apex was measured in end-diastole and end-systole. The distance travelled by the septal and lateral annulus from end-diastole to end-systole was calculated as septal and lateral MAPSE by subtracting the left ventricular end-systolic length (LVESL) from the left ventricular end-diastolic length (LVEDL) as shown on Fig. 1 . Average MAPSE was calculated as the average of septal and lateral MAPSEs.
LGE quantification
The extent of LGE was quantified visually using the standard left ventricular 17-segment model [18] . Each segment was visually scored for the total extent of LGE as previously described [19] . The 17 segments were grouped into four cardiac regions:
• anterior region, including segments 1, 7, 13 and 17;
• septal region, including segments 2, 3, 8, 9, 14 and 17;
• posterior region, including segments 4, 10, 15 and 17;
• lateral region, including segments 5, 6, 11, 12, 16 and 17.
To determine the LGE extent in the septal and lateral regions, the scores of these segments were summed. The resulting septal and lateral LGE extents were then expressed as a percentage of the maximum possible score of 24.
Echocardiography
In 20 randomly selected HCM patients, a retrospective analysis of the transthoracic echocardiograms (TTEs) obtained for clinical indications at the time of CMR examination using a commercially available ultrasound system (Vivid 7 or Vivid i, GE Ultrasound, Horten, Norway with a 2.5 MHz phased-array transducer) was performed. Additionally, a TTE analysis was performed in the first 20 healthy controls using the same ultrasound system. Standard echocardiographic images were obtained at end-expiratory apnoea. M-mode echocardiography through the mitral valve annulus, from the apical four-chamber view at both the septal and lateral annuli, was performed. The images were optimized for routine fourchamber view evaluation. The M-line was positioned through the medial and lateral annulus and included the tissue-blood border for easy identification of the motion of the annulus. The trough of the motion was defined as the end-diastolic position of the annulus, measured at the tip of the QRS complex. The peak was defined as the maximal systolic excursion point. All images were stored digitally and analysed offline by a single investigator blinded to CMR data using EchoPAC, GE Ultrasound.
Follow-up data and definition of study endpoints
Long-term follow-up was performed retrospectively by telephone contact. Reported clinical events were confirmed by review of the corresponding medical records in our electronic Hospital Information System or contact with the general practitioner, referring cardiologist or the treating hospital. The observer was unaware of the CMR results and collected data with a standardized questionnaire. The definition of major adverse cardiac event (MACE) required the documentation of cardiac death, heart transplantation or significant ventricular arrhythmia. In case of out-of-hospital death not followed by autopsy, sudden unexpected death was classified as cardiac death. Stroke was defined as neurological impairment and disability due to vascular causes lasting longer than 24 hours. Patients who had a stroke and suffered from a MACE over the course of follow-up were only counted regarding MACE.
Statistical analysis
Data are presented as mean ± standard deviation (with or without ranges) or counts and percentages. Continuous parameters were compared using a two-tailed student's ttest. Pearson's correlation was used to correlate septal, lateral and average MAPSE to the extent of LGE and to correlate the extent of LGE in septal regions to septal MAPSE and the extent of LGE in lateral regions to lateral MAPSE.
The level of agreement among the MAPSE measurements using CMR in healthy controls was evaluated using Bland-Altman analysis [20] . Intra-and inter-observer variabilities were assessed and expressed as mean difference between two measurements (d = bias), the standard deviation (SD) of the differences, the limits of agreement (d ± 1.96 × SD) and the coefficient of variation (CV = 2 × SD) [20] .
For septal, lateral and average MAPSE measurements, using either echocardiography or CMR, the interstudy reliability was assessed using Lin's concordance correlation coefficient (CCC) in 20 randomly selected healthy controls as well as 20 randomly selected patients with HCM [21] . A CCC value of 1 indicates perfect agreement; values < 0.5 were considered to be poor agreement; values between 0.5 and 0.7 to be moderate agreement; and values > 0.7 to be good to excellent agreement.
All results were considered statistically significant when P < 0.05. Analyses were performed with Statistical 1 Package for Social Sciences (SPSS for windows 14.0, Chicago, IL, USA).
Results
A total of 103 patients with HCM were enrolled during 2004-2012. Fifteen patients were excluded, due to incomplete clinical or CMR data (n = 10) or insufficient CMR image quality (n = 2 due to tachyarrhythmias, n = 3 due to difficulties in the angulation when planning the four-chamber view), yielding a total number of 88 patients finally included in this study. Baseline patient demographics and characteristics are presented in Table 1 . Fifty age-and sex-matched healthy subjects served as controls.
The CMR characteristics of patients with HCM and healthy controls are summarized in Table 2 . In healthy controls, septal and lateral MAPSE were comparable (1.28 ± 0.38 cm vs. 1.38 ± 0.40 cm; P = 0.3). Normal values for septal, lateral and average MAPSE were all approximately 0.9-2.5 cm (Table 2 ). In 50 healthy controls, CMR-derived MAPSE measurements showed an excellent reproducibility. Intra-and inter-observer variability for all MAPSE measurements was low, as indicated by the small biases (d) and low CVs for each measurement (Table 3) .
In all patients with HCM, septal, lateral and average MAPSE were all significantly reduced compared to healthy controls (Table 2) . In all patients with HCM, septal MAPSE was significantly reduced compared to lateral MAPSE (P = 0.01). In all patients with HCM, there was a moderate linear inverse relationship between LGE extent and reduced septal MAPSE (r = 0.34; P = 0.0015), average MAPSE (r = 0.35; P = 0.001) and lateral MAPSE (r = 0.34; P = 0.0015). Comparing the LGE extent in septal and lateral myocardial segments revealed a significantly elevated septal LGE extent (15 ± 18% vs. 6 ± 10%; P = 0.0001). The significantly increased septal LGE extent (15 ± 18%) was associated with a significantly reduced septal MAPSE (0.93 ± 0.33 cm). Comparing septal LGE extent to septal MAPSE revealed a weak linear relationship (r = 0.21; P = 0.06). In contrast, the lower LGE extent in lateral myocardial segments (6 ± 10%) resulted in a lesser reduction of lateral MAPSE (1.08 ± 0.37 cm). Nevertheless, the relationship between the lateral LGE extent and reduced lateral MAPSE was significant (r = 0.26; P = 0.02).
Looking at the subgroup of 37 patients with HOCM (Table 4) revealed that septal MAPSE (0.92 ± 0.37 cm) was significantly reduced compared to lateral MAPSE (1.10 ± 0.36 cm; P = 0.04). In patients with HOCM, as in the whole group of patients, the septal segments exhibited a significantly greater LGE extent compared to the lateral ones (11 ± 18% vs. 2 ± 6%; P = 0.01) accompanied by a septally accentuated reduction of MAPSE.
The same relation between septal and lateral MAPSE was observed in all 57 patients with HCM and LGE (Table 4) who also revealed a significantly lower septal MAPSE (0.90 ± 0.33 cm) compared to lateral MAPSE (1.06 ± 0.39 cm; P = 0.02). In these patients, septal myocardial segments also displayed more LGE extent than the lateral ones (24 ± 18% vs. 12 ± 14%; P < 0.0001), along with a more marked reduction of septal MAPSE. In contrast, septal (0.90 ± 0.32 cm) and lateral MAPSE (0.99 ± 0.35 cm; P = 0.2) were comparable in 51 patients with HNCM (Table 4 ). Looking at the total LGE extents, patients with HNCM revealed the largest amount of LGE. As opposed to the other subgroups, in patients with HNCM, the distribution of LGE extent in septal (17 ± 17%) and lateral myocardial segments (11 ± 14%; P = 0.07) was similar, resulting in an analogous reduction of septal and lateral MAPSE. The analysis of reduction in septal MAPSE compared to lateral MAPSE in all patients with HCM, patients with HOCM, patients with HNCM and patients with LGE, as well as the extent of LGE in septal compared to lateral myocardial segments in these patients is visualized on Fig. 2 . In 31 patients with HCM, no LGE was detectable. These patients also presented with a comparable reduction of septal and lateral MAPSE (0.99 ± 0.33 cm vs. 1.11 ± 0.33 cm; P = 0.2; Table 4 ).
In a subgroup analysis of 20 healthy controls and 20 patients with HCM, MAPSE measurements were comparable between echocardiography and CMR ( Table 5 ). The interstudy reliability for the measurement of septal and lateral MAPSE in healthy controls and patients with HCM using echocardiography and CMR was excellent as indicated by high CCCs (0.94-0.99) (Fig. 3) .
During a follow-up period of 5.1 ± 3.3 years, three patients (3.4%) suffered from cardiac death, one (1.1%) underwent heart transplantation and two patients (2.3%) with an implantable cardioverter defibrillator experienced shock therapies due to ventricular arrhythmias. Compared to patients without events, those suffering from a MACE presented with significantly reduced septal (0.60 ± 0.18 vs. 0.96 ± 0.33 cm; P = 0.01), lateral (0.77 ± 0.19 vs. 1.10 ± 0.37 cm; P = 0.04) and average MAPSE (0.69 ± 0.19 vs. 1.02 ± 0.31 cm; P = 0.01) as well as a significantly greater amount of LGE (58.8 ± 14.9% vs. 23.7 ± 25.9%; P = 0.002). Ten patients (11.4%) suffered from stroke during follow-up. The occurrence of stroke was also related to a significantly reduced septal MAPSE (0.73 ± 0.27 vs. 0.96 ± 0.33 cm; P = 0.04) as well as a significantly more pronounced LGE extent (46.4 ± 28.9% vs. 23.7 ± 25.9%; P = 0.01) compared to asymptomatic patients. Lateral (0.92 ± 0.32 vs. 1.10 ± 0.37 cm; P = 0.15) and average MAPSE (0.82 ± 0.27 vs. 1.02 ± 0.31 cm; P = 0.06) only showed a trend towards lower values in HCM patients with stroke compared to HCM patients without events.
Discussion
To the best of or knowledge, the present study is the first to report CMR-acquired measurements for MAPSE in healthy subjects and in patients with HCM. Our results showed that CMR-assessed MAPSE measurements can be easily obtained and reveal an excellent reproducibility in terms of intra-and inter-observer variability. Furthermore, we provide reference values for MAPSE measurements in healthy controls using both the basal septal mitral annulus (septal MAPSE) and the basal lateral mitral annulus (lateral MAPSE). The values for septal and lateral MAPSE were comparable among healthy controls. These findings are in line with a previous study using CMR tagging sequences [22] , which showed comparable values for septal and lateral longitudinal displacement in a healthy control group. In routine clinical practice, MAPSE is usually measured echocardiographically on the lateral annular site. In the current literature, to date there is no consensus on the best site to measure MAPSE [5] [6] [7] [8] . Using CMR-derived MAPSE measurements, we obtained a slightly better intraand inter-observer reproducibility compared to previous echocardiography studies [23] . This may be due to the fact that, in contrast to echocardiographical measurements, CMR allows the free choice of a reference point outside the left ventricular apex so that MAPSE measurements are not angle dependent and therefore more robust. Moreover, a subgroup analysis among healthy controls as well as patients with HCM using either echocardiography or CMR revealed comparable MAPSE measurements.
Histopathologically, HCM is characterized by cardiomyocyte and cardiac hypertrophy, myocyte disarray, interstitial and replacement fibrosis as well as dysplastic intramyocardial arterioles [1, 2] . These histopathological changes result in a diastolic dysfunction and, later in the disease course, might also provoke systolic longitudinal function impairment, which is associated with poor prognosis [24, 25] . In patients with heart failure, MAPSE correlated with parameters of systolic longitudinal and diastolic dysfunction as well as with left ventricular twist and torsion [5] . Therefore, we hypothesized that MAPSE measurements using CMR might also be altered in patients with HCM. The left ventricular myocardial region of the confluence of the basal anterior and inferior septum with the contiguous anterior free wall is the most frequent location for increased wall thickness in patients with HCM [26] . Thus, we assumed that the corresponding septal MAPSE might be most affected.
As expected, our findings showed significantly reduced values for all MAPSE measurements in patients with HCM compared to those obtained in healthy controls. Contrary to healthy controls, in the whole group of patients with HCM, as well as in patients with HOCM and in all HCM patients with LGE, septal MAPSE was significantly reduced compared to lateral MAPSE. In line with our results, Kramer et al. [9] and Young et al. [22] also found significantly reduced values for septal compared to lateral longitudinal displacement in HCM populations in contrast to healthy subjects using CMR tagging. At that time, since LGE was not yet available, in order to enable an in vivo tissue characterization, the authors [9, 22] hypothesized that their findings may be due to a more pronounced myocardial disarray in the septal and anteroseptal region than in the lateral wall. In the present study, using state of the art CMR imaging, we showed that septal myocardial segments revealed a significantly higher LGE extent than lateral myocardial segments in the whole group of patients with HCM as well as in the subgroups of patients with HOCM and those with LGE. In contrast to these findings, in the subgroup of patients with HNCM and/or in those HCM patients without the presence of LGE, septal and lateral MAPSE were comparably reduced. Although the total amount of LGE was significantly greater in HNCM patients than in patients with HOCM, the distribution pattern of LGE was different. HNCM patients revealed a more 'balanced' LGE, being more equally distributed to the septal and lateral myocardial segments, explaining the analogous reduction of septal and lateral MAPSE in these patients. Furthermore, reduced MAPSE measurements showed a significant inverse correlation with the LGE extent. This fact could suggest a possible link between reduced MAPSE measurements, fibrotic tissue and longitudinal dysfunction.
During the 5.1-year follow-up, six patients (6.8%) suffered from MACE and 10 patients (11.4%) suffered from stroke. We found that, in patients suffering from MACE or stroke, MAPSE was significantly reduced and the amount of LGE was significantly greater compared to patients without events. These results are in line with previous studies [27] [28] [29] [30] , highlighting the clinical importance of LGE as an independent risk factor for predicting sudden cardiac death and adverse outcomes in patients with HCM. Reduced MAPSE has proven to be a risk factor for MACE in patients with heart failure due to ischaemic heart disease and atrial fibrillation [31] [32] [33] as well as in critically ill patients with shock [34] . The results of our present study suggest that a reduced septal MAPSE might also have prognostic implication in patients with HCM. result in a further reduction of MAPSE. Furthermore, the measurement of MAPSE only requires the acquisition of a four-chamber cine view, which is always obtained in clinical routine. No specific sequences or post-processing software are needed for analysis. Therefore, MAPSE is easy to obtain and could be used as a reproducible, longitudinal monitoring tool for LGE changes and might also predict an unfavourable prognosis. However, further longitudinal studies are needed to prove this hypothesis.
Conclusions
MAPSE measurement using CMR is feasible, reproducible and comparable to echocardiography in healthy controls and patients with HCM. In patients with HCM, all MAPSE measurements were significantly reduced compared to those measurements in healthy subjects. In healthy controls, values for septal and lateral MAPSE were comparable. This finding did not hold true for patients with HCM. In line with a more pronounced LGE amount in the septal myocardial segments, the whole group of HCM patients, as well as the subgroup of patients with HOCM and all patients with HCM and evidence of LGE, revealed a significant reduction of septal compared to lateral MAPSE. The subgroup of patients with HNCM revealed a more balanced distribution of LGE in the septal and lateral myocardial segments along with a more comparable reduction of septal and lateral MAPSE. Furthermore, septal and lateral MAPSE were similar in patients with HCM without LGE. Therefore, reduced MAPSE seems to be an easy determinable surrogate marker of fibrosis leading to left ventricular mechanical dysfunction in patients with HCM. MAPSE measurement might serve as an easily measurable, reproducible, longitudinal monitoring tool for fibrotic changes in these patients. Moreover, in patients with HCM suffering from MACE or stroke, MAPSE was significantly reduced and the amount of LGE was significantly greater compared to patients without events. These results suggest that a reduced MAPSE might also have a prognostic implication.
